Ask Warren

Cellbion

308430 · KOSDAQ · ₩308430 · 셀비온

₩11,670▼ ₩1,050 (8.25%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Revenue₩472M₩613M₩382M₩679M₩404M₩480M₩567M
Cost of sales₩461M₩613M₩344M₩824M₩350M₩338M₩542M
Gross profit₩11M−₩730,253₩37M−₩145M₩55M₩141M₩25M
Operating income−₩2.6B−₩2.4B−₩2.5B−₩2B−₩2.1B−₩1.7B−₩2.2B
Net income₩17B−₩2.4B−₩5.7B₩63M−₩466M−₩1.4B−₩5.6B
Net income to shareholders₩17B−₩2.4B−₩5.7B₩63M−₩466M−₩1.4B−₩5.6B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Total assets₩83B₩32B₩35B₩33B₩32B₩34B₩34B
Current assets₩70B₩21B₩25B₩28B₩30B₩31B₩32B
Cash and equivalents₩1.7B₩2B₩2B₩1.8B₩1.8B₩1.4B₩1.2B
Total liabilities₩47B₩12B₩12B₩8.7B₩5.5B₩5.7B₩4.8B
Current liabilities₩2.1B₩1.8B₩2.3B₩1.6B₩1B₩1.3B₩1.1B
Borrowings₩7B₩1.5B₩1.5B₩1.5B₩1.5B₩1.5B₩1.5B
Total equity₩36B₩21B₩23B₩25B₩26B₩28B₩30B
Shareholders' equity₩36B₩21B₩23B₩25B₩26B₩28B₩30B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cash from operations−₩1.9B−₩2.4B−₩1.5B−₩1B−₩1.6B−₩1.4B−₩1.9B
Capital spending−₩3.8B₩1.3B₩875M₩739M−₩256M₩113M₩30M
Free cash flow−₩5.7B−₩3.6B−₩2.4B−₩1.8B−₩1.8B−₩1.5B−₩1.9B

Consolidated where available. Amounts in won.

Also known as: Cellbion / 셀비온 / 308430 / KRX:308430

Source: KRX statistical information